nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprazolam—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.109	0.167	CbGbCtD
Alprazolam—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.109	0.167	CbGbCtD
Alprazolam—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0821	0.125	CbGbCtD
Alprazolam—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0551	0.0839	CbGbCtD
Alprazolam—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.0503	0.0766	CbGbCtD
Alprazolam—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.0503	0.0766	CbGbCtD
Alprazolam—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0377	0.0574	CbGbCtD
Alprazolam—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0345	0.0526	CbGbCtD
Alprazolam—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0344	0.0525	CbGbCtD
Alprazolam—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.032	0.0488	CbGbCtD
Alprazolam—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0236	0.0359	CbGbCtD
Alprazolam—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0147	0.0224	CbGbCtD
Alprazolam—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0135	0.0205	CbGbCtD
Alprazolam—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00919	0.014	CbGbCtD
Alprazolam—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000236	0.000686	CcSEcCtD
Alprazolam—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000235	0.000685	CcSEcCtD
Alprazolam—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000235	0.000685	CcSEcCtD
Alprazolam—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.000682	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000233	0.000679	CcSEcCtD
Alprazolam—Infection—Etoposide—peripheral nervous system neoplasm	0.000233	0.000678	CcSEcCtD
Alprazolam—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.000677	CcSEcCtD
Alprazolam—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000232	0.000676	CcSEcCtD
Alprazolam—Nausea—Melphalan—peripheral nervous system neoplasm	0.000232	0.000676	CcSEcCtD
Alprazolam—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000231	0.000673	CcSEcCtD
Alprazolam—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000231	0.000673	CcSEcCtD
Alprazolam—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00023	0.000669	CcSEcCtD
Alprazolam—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000229	0.000666	CcSEcCtD
Alprazolam—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000229	0.000666	CcSEcCtD
Alprazolam—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000229	0.000666	CcSEcCtD
Alprazolam—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.000665	CcSEcCtD
Alprazolam—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000228	0.000664	CcSEcCtD
Alprazolam—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000227	0.000663	CcSEcCtD
Alprazolam—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000226	0.00066	CcSEcCtD
Alprazolam—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.000651	CcSEcCtD
Alprazolam—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000223	0.00065	CcSEcCtD
Alprazolam—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000222	0.000647	CcSEcCtD
Alprazolam—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000221	0.000645	CcSEcCtD
Alprazolam—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000221	0.000644	CcSEcCtD
Alprazolam—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.000644	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000221	0.000643	CcSEcCtD
Alprazolam—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000219	0.000638	CcSEcCtD
Alprazolam—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000218	0.000635	CcSEcCtD
Alprazolam—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000629	CcSEcCtD
Alprazolam—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000215	0.000627	CcSEcCtD
Alprazolam—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000215	0.000625	CcSEcCtD
Alprazolam—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000214	0.000622	CcSEcCtD
Alprazolam—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000214	0.000622	CcSEcCtD
Alprazolam—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000213	0.000621	CcSEcCtD
Alprazolam—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000213	0.000621	CcSEcCtD
Alprazolam—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000212	0.000618	CcSEcCtD
Alprazolam—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000211	0.000614	CcSEcCtD
Alprazolam—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000211	0.000614	CcSEcCtD
Alprazolam—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00021	0.000613	CcSEcCtD
Alprazolam—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.00021	0.000612	CcSEcCtD
Alprazolam—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000209	0.000609	CcSEcCtD
Alprazolam—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000209	0.000608	CcSEcCtD
Alprazolam—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000208	0.000607	CcSEcCtD
Alprazolam—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000207	0.000604	CcSEcCtD
Alprazolam—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000206	0.0006	CcSEcCtD
Alprazolam—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000206	0.0006	CcSEcCtD
Alprazolam—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000206	0.0006	CcSEcCtD
Alprazolam—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000206	0.000599	CcSEcCtD
Alprazolam—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000205	0.000598	CcSEcCtD
Alprazolam—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000204	0.000595	CcSEcCtD
Alprazolam—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000204	0.000594	CcSEcCtD
Alprazolam—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000204	0.000593	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000202	0.000589	CcSEcCtD
Alprazolam—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000202	0.000589	CcSEcCtD
Alprazolam—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000202	0.000588	CcSEcCtD
Alprazolam—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000585	CcSEcCtD
Alprazolam—Constipation—Etoposide—peripheral nervous system neoplasm	0.0002	0.000584	CcSEcCtD
Alprazolam—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000582	CcSEcCtD
Alprazolam—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.000578	CcSEcCtD
Alprazolam—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000198	0.000578	CcSEcCtD
Alprazolam—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000198	0.000576	CcSEcCtD
Alprazolam—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000575	CcSEcCtD
Alprazolam—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.000575	CcSEcCtD
Alprazolam—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000568	CcSEcCtD
Alprazolam—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000195	0.000567	CcSEcCtD
Alprazolam—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.000566	CcSEcCtD
Alprazolam—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000194	0.000566	CcSEcCtD
Alprazolam—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.000563	CcSEcCtD
Alprazolam—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000193	0.000562	CcSEcCtD
Alprazolam—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000192	0.00056	CcSEcCtD
Alprazolam—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000191	0.000558	CcSEcCtD
Alprazolam—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000191	0.000557	CcSEcCtD
Alprazolam—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000191	0.000556	CcSEcCtD
Alprazolam—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.000555	CcSEcCtD
Alprazolam—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.000555	CcSEcCtD
Alprazolam—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.000555	CcSEcCtD
Alprazolam—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000189	0.000551	CcSEcCtD
Alprazolam—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000189	0.000551	CcSEcCtD
Alprazolam—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.00055	CcSEcCtD
Alprazolam—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000188	0.000549	CcSEcCtD
Alprazolam—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000188	0.000548	CcSEcCtD
Alprazolam—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000186	0.000542	CcSEcCtD
Alprazolam—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000541	CcSEcCtD
Alprazolam—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000185	0.000539	CcSEcCtD
Alprazolam—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000185	0.000539	CcSEcCtD
Alprazolam—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000185	0.000538	CcSEcCtD
Alprazolam—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000184	0.000536	CcSEcCtD
Alprazolam—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000184	0.000536	CcSEcCtD
Alprazolam—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000183	0.000534	CcSEcCtD
Alprazolam—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.000532	CcSEcCtD
Alprazolam—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000532	CcSEcCtD
Alprazolam—Rash—Vincristine—peripheral nervous system neoplasm	0.000182	0.000531	CcSEcCtD
Alprazolam—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000182	0.000531	CcSEcCtD
Alprazolam—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000182	0.00053	CcSEcCtD
Alprazolam—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000529	CcSEcCtD
Alprazolam—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000528	CcSEcCtD
Alprazolam—Headache—Vincristine—peripheral nervous system neoplasm	0.000181	0.000528	CcSEcCtD
Alprazolam—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.000525	CcSEcCtD
Alprazolam—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.000523	CcSEcCtD
Alprazolam—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000178	0.000519	CcSEcCtD
Alprazolam—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000175	0.00051	CcSEcCtD
Alprazolam—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000175	0.000509	CcSEcCtD
Alprazolam—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000173	0.000503	CcSEcCtD
Alprazolam—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000173	0.000503	CcSEcCtD
Alprazolam—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000172	0.000502	CcSEcCtD
Alprazolam—Nausea—Vincristine—peripheral nervous system neoplasm	0.000172	0.0005	CcSEcCtD
Alprazolam—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000171	0.0005	CcSEcCtD
Alprazolam—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000498	CcSEcCtD
Alprazolam—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000496	CcSEcCtD
Alprazolam—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000492	CcSEcCtD
Alprazolam—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000491	CcSEcCtD
Alprazolam—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000168	0.00049	CcSEcCtD
Alprazolam—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.00049	CcSEcCtD
Alprazolam—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000168	0.000488	CcSEcCtD
Alprazolam—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000488	CcSEcCtD
Alprazolam—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000485	CcSEcCtD
Alprazolam—Chills—Epirubicin—peripheral nervous system neoplasm	0.000166	0.000483	CcSEcCtD
Alprazolam—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000166	0.000483	CcSEcCtD
Alprazolam—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000163	0.000474	CcSEcCtD
Alprazolam—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000472	CcSEcCtD
Alprazolam—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000471	CcSEcCtD
Alprazolam—Rash—Cisplatin—peripheral nervous system neoplasm	0.000161	0.00047	CcSEcCtD
Alprazolam—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000161	0.000469	CcSEcCtD
Alprazolam—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000469	CcSEcCtD
Alprazolam—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00016	0.000467	CcSEcCtD
Alprazolam—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000466	CcSEcCtD
Alprazolam—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000464	CcSEcCtD
Alprazolam—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000462	CcSEcCtD
Alprazolam—Tension—Epirubicin—peripheral nervous system neoplasm	0.000158	0.00046	CcSEcCtD
Alprazolam—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000156	0.000455	CcSEcCtD
Alprazolam—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000156	0.000453	CcSEcCtD
Alprazolam—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000452	CcSEcCtD
Alprazolam—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000155	0.000451	CcSEcCtD
Alprazolam—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000451	CcSEcCtD
Alprazolam—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000449	CcSEcCtD
Alprazolam—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000447	CcSEcCtD
Alprazolam—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000152	0.000442	CcSEcCtD
Alprazolam—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000442	CcSEcCtD
Alprazolam—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000436	CcSEcCtD
Alprazolam—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000435	CcSEcCtD
Alprazolam—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000149	0.000434	CcSEcCtD
Alprazolam—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000434	CcSEcCtD
Alprazolam—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000431	CcSEcCtD
Alprazolam—Rash—Etoposide—peripheral nervous system neoplasm	0.000148	0.00043	CcSEcCtD
Alprazolam—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000148	0.00043	CcSEcCtD
Alprazolam—Ketazolam—ABCB1—peripheral nervous system neoplasm	0.000147	0.27	CrCbGaD
Alprazolam—Headache—Etoposide—peripheral nervous system neoplasm	0.000147	0.000427	CcSEcCtD
Alprazolam—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000426	CcSEcCtD
Alprazolam—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000423	CcSEcCtD
Alprazolam—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000421	CcSEcCtD
Alprazolam—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000421	CcSEcCtD
Alprazolam—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000144	0.00042	CcSEcCtD
Alprazolam—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000419	CcSEcCtD
Alprazolam—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000417	CcSEcCtD
Alprazolam—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000414	CcSEcCtD
Alprazolam—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000412	CcSEcCtD
Alprazolam—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000409	CcSEcCtD
Alprazolam—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000406	CcSEcCtD
Alprazolam—Nausea—Etoposide—peripheral nervous system neoplasm	0.000139	0.000405	CcSEcCtD
Alprazolam—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000402	CcSEcCtD
Alprazolam—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000399	CcSEcCtD
Alprazolam—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000399	CcSEcCtD
Alprazolam—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000399	CcSEcCtD
Alprazolam—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000399	CcSEcCtD
Alprazolam—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000398	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000396	CcSEcCtD
Alprazolam—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000394	CcSEcCtD
Alprazolam—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000391	CcSEcCtD
Alprazolam—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000134	0.00039	CcSEcCtD
Alprazolam—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.00039	CcSEcCtD
Alprazolam—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000389	CcSEcCtD
Alprazolam—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000386	CcSEcCtD
Alprazolam—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000383	CcSEcCtD
Alprazolam—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000383	CcSEcCtD
Alprazolam—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000381	CcSEcCtD
Alprazolam—Infection—Epirubicin—peripheral nervous system neoplasm	0.00013	0.00038	CcSEcCtD
Alprazolam—Shock—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000376	CcSEcCtD
Alprazolam—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000376	CcSEcCtD
Alprazolam—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000375	CcSEcCtD
Alprazolam—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000373	CcSEcCtD
Alprazolam—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000372	CcSEcCtD
Alprazolam—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000127	0.00037	CcSEcCtD
Alprazolam—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000369	CcSEcCtD
Alprazolam—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000369	CcSEcCtD
Alprazolam—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000369	CcSEcCtD
Alprazolam—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000368	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000367	CcSEcCtD
Alprazolam—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000365	CcSEcCtD
Alprazolam—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000365	CcSEcCtD
Alprazolam—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000361	CcSEcCtD
Alprazolam—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000357	CcSEcCtD
Alprazolam—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000357	CcSEcCtD
Alprazolam—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000354	CcSEcCtD
Alprazolam—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000352	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000348	CcSEcCtD
Alprazolam—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000348	CcSEcCtD
Alprazolam—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000347	CcSEcCtD
Alprazolam—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000346	CcSEcCtD
Alprazolam—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000345	CcSEcCtD
Alprazolam—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000344	CcSEcCtD
Alprazolam—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000343	CcSEcCtD
Alprazolam—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000342	CcSEcCtD
Alprazolam—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000341	CcSEcCtD
Alprazolam—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000117	0.00034	CcSEcCtD
Alprazolam—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000337	CcSEcCtD
Alprazolam—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000337	CcSEcCtD
Alprazolam—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000333	CcSEcCtD
Alprazolam—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000331	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000113	0.00033	CcSEcCtD
Alprazolam—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000113	0.00033	CcSEcCtD
Alprazolam—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000327	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000322	CcSEcCtD
Alprazolam—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.00032	CcSEcCtD
Alprazolam—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000318	CcSEcCtD
Alprazolam—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000316	CcSEcCtD
Alprazolam—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000315	CcSEcCtD
Alprazolam—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000315	CcSEcCtD
Alprazolam—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000313	CcSEcCtD
Alprazolam—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000312	CcSEcCtD
Alprazolam—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000308	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000306	CcSEcCtD
Alprazolam—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000305	CcSEcCtD
Alprazolam—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000304	CcSEcCtD
Alprazolam—Clobazam—ABCB1—peripheral nervous system neoplasm	0.000104	0.191	CrCbGaD
Alprazolam—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000303	CcSEcCtD
Alprazolam—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000302	CcSEcCtD
Alprazolam—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000302	CcSEcCtD
Alprazolam—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000292	CcSEcCtD
Alprazolam—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	9.93e-05	0.000289	CcSEcCtD
Alprazolam—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	9.67e-05	0.000282	CcSEcCtD
Alprazolam—Urticaria—Doxorubicin—peripheral nervous system neoplasm	9.65e-05	0.000281	CcSEcCtD
Alprazolam—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	9.6e-05	0.00028	CcSEcCtD
Alprazolam—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	9.6e-05	0.00028	CcSEcCtD
Alprazolam—Asthenia—Epirubicin—peripheral nervous system neoplasm	9.42e-05	0.000274	CcSEcCtD
Alprazolam—Pruritus—Epirubicin—peripheral nervous system neoplasm	9.29e-05	0.000271	CcSEcCtD
Alprazolam—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	8.98e-05	0.000262	CcSEcCtD
Alprazolam—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	8.95e-05	0.000261	CcSEcCtD
Alprazolam—Asthenia—Doxorubicin—peripheral nervous system neoplasm	8.71e-05	0.000254	CcSEcCtD
Alprazolam—Dizziness—Epirubicin—peripheral nervous system neoplasm	8.68e-05	0.000253	CcSEcCtD
Alprazolam—Nitrazepam—ABCB1—peripheral nervous system neoplasm	8.61e-05	0.158	CrCbGaD
Alprazolam—Pruritus—Doxorubicin—peripheral nervous system neoplasm	8.59e-05	0.00025	CcSEcCtD
Alprazolam—Vomiting—Epirubicin—peripheral nervous system neoplasm	8.35e-05	0.000243	CcSEcCtD
Alprazolam—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	8.31e-05	0.000242	CcSEcCtD
Alprazolam—Rash—Epirubicin—peripheral nervous system neoplasm	8.28e-05	0.000241	CcSEcCtD
Alprazolam—Dermatitis—Epirubicin—peripheral nervous system neoplasm	8.27e-05	0.000241	CcSEcCtD
Alprazolam—Headache—Epirubicin—peripheral nervous system neoplasm	8.22e-05	0.00024	CcSEcCtD
Alprazolam—Dizziness—Doxorubicin—peripheral nervous system neoplasm	8.03e-05	0.000234	CcSEcCtD
Alprazolam—Nausea—Epirubicin—peripheral nervous system neoplasm	7.8e-05	0.000227	CcSEcCtD
Alprazolam—Vomiting—Doxorubicin—peripheral nervous system neoplasm	7.72e-05	0.000225	CcSEcCtD
Alprazolam—Rash—Doxorubicin—peripheral nervous system neoplasm	7.66e-05	0.000223	CcSEcCtD
Alprazolam—Flurazepam—ABCB1—peripheral nervous system neoplasm	7.65e-05	0.14	CrCbGaD
Alprazolam—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	7.65e-05	0.000223	CcSEcCtD
Alprazolam—Headache—Doxorubicin—peripheral nervous system neoplasm	7.61e-05	0.000222	CcSEcCtD
Alprazolam—Nausea—Doxorubicin—peripheral nervous system neoplasm	7.21e-05	0.00021	CcSEcCtD
Alprazolam—Midazolam—ABCB1—peripheral nervous system neoplasm	7.09e-05	0.13	CrCbGaD
Alprazolam—Diazepam—ABCB1—peripheral nervous system neoplasm	6.08e-05	0.111	CrCbGaD
